RESMED INC — Director's Dealing 2016

Jan 19, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-01-15

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-15	ResMed Common Stock	M	5975	$33.70	Acquired	150852.849	Direct
2016-01-15	ResMed Common Stock	S	975	$52.94	Disposed	149877.849	Direct
2016-01-15	ResMed Common Stock	S	5000	$53.092	Disposed	144877.849	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-15	ResMed Common Stock Options	$33.70	M	5975	Disposed	2017-11-11	ResMed Commmon Stock (5975)	Direct

Footnotes

F1: The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.

F2: Represents date options first became exercisable. Options vest 1/4 annually.